The recipient of the first genetically modified pig kidney transplant, Richard “Rick” Slayman, has passed away two months after undergoing the groundbreaking procedure.
Massachusetts General Hospital (MGH), where the operation took place in March, announced on Sunday, May 12, that Mr. Slayman, aged 62, had died. They emphasized that there was no indication his death was linked to the transplant.
While transplants involving organs from genetically modified pigs have previously failed, Mr. Slayman’s operation was regarded as a significant milestone in medical history. Suffering from end-stage kidney disease, Type 2 diabetes, and hypertension, he underwent the transplant after experiencing kidney failure five years following a human kidney transplant in 2018.
Following the pig kidney transplant on March 16, Mr. Slayman’s doctors reported that the new organ was functioning well, eliminating the need for dialysis.
In a statement, MGH expressed deep gratitude to Mr. Slayman for his willingness to advance xenotransplantation, the process of transplanting living cells, tissues, or organs from one species to another. They mourned his sudden passing and extended condolences to his family.
Mr. Slayman’s relatives described him as an inspiration, noting his desire to provide hope to thousands of transplant patients. They remembered him as a kind-hearted individual with a quick wit and unwavering dedication to his loved ones.
While Mr. Slayman’s pig kidney transplant was groundbreaking, it wasn’t the first pig organ used in a transplant. Two other patients received pig heart transplants, but unfortunately, they passed away shortly afterward. In one instance, signs of organ rejection were observed, highlighting the inherent risks associated with transplants.
